ProPharma, a pioneer in RNAi technology
ProPharma, a biopharmaceutical company ProWorld Group, a pioneer in research and development of new drugs based on the technology of gene silencing by RNA interference (RNAi), one of the top four companies worldwide with products based on RNAi technology clinical trials, has received the grant by the Spanish Agency for Medicines and Medical Devices (Competent Authority) for approval as a drug manufacturer pharmaceutical research.
The laboratory's technical director, Veronica Rose, said:
"We are very proud of our company and each day of work we have done since its founding in 2006. ProPharma has received the approval of pharmaceutical is further evidence of the effort and hopes placed in this project from ProWorld and from the people who give shape to this company. "